• Adverse effects of androgen deprivation therapy in patients with prostate cancer: Focus on metabolic complications 

      Tzortzis V., Samarinas M., Zachos I., Oeconomou A., Pisters L.L., Bargiota A. (2017)
      Prostate cancer is the most common cancer among men and androgen deprivation therapy (ADT) is the most effective treatment for this disease. The cornerstone of the treatment of prostate cancer is inhibition of testosterone ...
    • Expert consensus on the rational clinical use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors 

      Achimastos A., Alexandrides T., Alexopoulos D., Athyros V., Bargiota A., Bilianou E., Chrysochoou C., Drogari E., Elisaf M., Ganotakis E., Goudevenos I., Ioannidis I., Kolovou G., Kotsis V., Lekakis I., Liberopoulos E., Melidonis A., Nikolaou V., Ntaios G., Papanas N., Pappas S., Pitsavos C., Rallidis L., Richter D., Skoumas I., Tentolouris N., Tousoulis D., Tselepis A., Tsioufis K., Tziakas D., Tziomalos K., Vardas P., Vlachopoulo C., Vlahakos D. (2016)
      Two proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, evolocumab and alirocumab, have recently been approved by both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for the ...
    • Prevalence and determinants of type 2 diabetes mellitus in a Greek adult population 

      Tsirona S., Katsaros F., Bargiota A., Polyzos S.A., Arapoglou G., Koukoulis G.N. (2016)
      The prevalence of diabetes mellitus (DM) is increasing worldwide reaching epidemic proportions. The aim of the present study was to estimate the prevalence of DM in Thessaly, a large region of Central Greece, and to ...
    • Sarcopenia: From definition to treatment 

      Dionyssiotis Y., Kapsokoulou A., Samlidi E., Angoules A.G., Papathanasiou J., Chronopoulos E., Kostoglou-Athanassiou I., Trovas G. (2017)
      [No abstract available]